Overview
Status
Active
Registry date
2018-03-26
Share capital
5,000.00 PLN
Registered address
ul. Franciszka Klimczaka 1, 02-797 Warszawa, Poland
Financials
Filing timeliness
No financial statement for 2019 – the filing deadline has passed.
- 2019not filed
- 201810/04/2019
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2018.
Results vs industry
Revenue
This companyUSD 14.13kMedianUSD 1.06mAverageUSD 22.40m
Net profit
This companyUSD -11.62kMedianUSD 37.33kAverageUSD 880.24k
Operating costs
This companyUSD 25.75kMedianUSD 922.77kAverageUSD 21.08m
Assets
This companyUSD 134.89kMedianUSD 608.93kAverageUSD 11.85m
Industry
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Jakub Dawid Kordaage 41 | 40 | $540.25 | 40% |
Daniel Zagórskiage 34 | 60 | $810.37 | 60% |
Manner of representation
Each member of the management board is authorized individually to make declarations of will and sign on behalf of the company.
Beneficial owners
No beneficial owners recorded for the company Imex Pharm.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Vorwarts Pharmasp. z o.o. | $210,138.62 | vorwartspharma.pl | ||
| Black & Whitesp. z o.o. | $154,866.36 | polonus.pl | ||
| Osteoprofsp. z o.o. | $72,065.80 | osteoprof.pl | ||
| THC PharmaS.A. | $39,093.70 | thc-pharma.pl | ||
| EDGE Pharmasp. z o.o. | $19,855.64 | edgepharma.eu | ||
| Arcade Internationalsp. z o.o. | $17,817.26 | arcade-int.pl | ||
| Filicosp. z o.o. | $11,710.75 | filico.eu | ||
| Get Ready Wheelchairssp. z o.o. | $9,842.54 | getreadywheelchairs.com | ||
| Jacek Waksmundzki Trust 2S.K.A. | $5,769.53 | trust.pl | ||
| Optimedussp. z o.o. | $1.00 | optimedus.pl |
FAQ
The main business activity of Imex Pharm focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on March 26, 2018.
The headquarters is located at: ul. Franciszka Klimczaka 1, 02-797 Warszawa.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2018 to December 31, 2018.
The company reported a revenue of $14,130 in 2018.
No, in 2018 the company reported a net loss of $11,623.
The largest operating cost category falls under external services. This category amounted to $19,718 in 2018, representing 77% of all operating expenses.
Last updated: 2026-04-29